TreeWAS – Variant ID: rs17552189

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T36-T50 Poisoning by drugs, medicaments and biological substances	0.107	0.893	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.102	0.898	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.100	0.900	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.099	0.901	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.097	0.903	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.097	0.903	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.096	0.904	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.094	0.906	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.089	0.911	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.088	0.912	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.088	0.912	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.088	0.912	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.087	0.913	0.000
T39.0 Salicylates	0.087	0.913	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.085	0.915	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.083	0.917	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.083	0.917	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.083	0.917	0.000
T36 Poisoning by systemic antibiotics	0.083	0.917	0.000
T47.0 Histamine H(2)-receptor antagonists	0.081	0.918	0.000
T38.1 Thyroid hormones and substitutes	0.081	0.919	0.000
T47.6 Antidiarrhoeal drugs	0.080	0.920	0.000
T46.1 Calcium-channel blockers	0.078	0.922	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.078	0.922	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.077	0.923	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.077	0.923	0.000
T47.2 Stimulant laxatives	0.076	0.924	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.076	0.924	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.075	0.925	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.075	0.925	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.075	0.925	0.000
T42.1 Iminostilbenes	0.075	0.925	0.000
T42.3 Barbiturates	0.074	0.926	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.074	0.926	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.073	0.926	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.073	0.926	0.000
T46.7 Peripheral vasodilators	0.073	0.926	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.073	0.927	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.073	0.927	0.000
T38.0 Glucocorticoids and synthetic analogues	0.073	0.927	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.073	0.927	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.073	0.927	0.000
T39.4 Antirheumatics, not elsewhere classified	0.072	0.928	0.000
T39.2 Pyrazolone derivatives	0.072	0.928	0.000
T50.4 Drugs affecting uric acid metabolism	0.072	0.928	0.000
T42.4 Benzodiazepines	0.072	0.928	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.071	0.929	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.071	0.929	0.000
T47.7 Emetics	0.071	0.929	0.000
T47.5 Digestants	0.071	0.929	0.000
T47.4 Other laxatives	0.071	0.929	0.000
T47.3 Saline and osmotic laxatives	0.071	0.929	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.071	0.929	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.070	0.930	0.000
T42.2 Succinimides and oxazolidinediones	0.070	0.930	0.000
T50.7 Analeptics and opioid receptor antagonists	0.069	0.930	0.000
T50.5 Appetite depressants	0.069	0.930	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.069	0.930	0.000
T50.1 Loop [high-ceiling] diuretics	0.069	0.930	0.000
T50.0 Mineralocorticoids and their antagonists	0.069	0.930	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.069	0.931	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.069	0.931	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.069	0.931	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.069	0.931	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.069	0.931	0.000
T44.0 Anticholinesterase agents	0.069	0.931	0.000
T50.8 Diagnostic agents	0.069	0.931	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.068	0.932	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.068	0.932	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.067	0.932	0.000
T38.9 Other and unspecified hormone antagonists	0.067	0.933	0.000
T38.7 Androgens and anabolic congeners	0.067	0.933	0.000
T38.5 Other oestrogens and progestogens	0.067	0.933	0.000
T38.4 Oral contraceptives	0.067	0.933	0.000
T38.2 Antithyroid drugs	0.067	0.933	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.067	0.933	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.065	0.935	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.064	0.936	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.063	0.936	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.063	0.936	0.000
T42.0 Hydantoin derivatives	0.063	0.937	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.062	0.937	0.000
T39.1 4-Aminophenol derivatives	0.060	0.940	0.000
T36.9 Systemic antibiotic, unspecified	0.059	0.940	0.000
T36.8 Other systemic antibiotics	0.059	0.940	0.000
T36.7 Antifungal antibiotics, systemically used	0.059	0.940	0.000
T36.6 Rifamycins	0.059	0.940	0.000
T36.5 Aminoglycosides	0.059	0.940	0.000
T36.4 Tetracyclines	0.059	0.940	0.000
T36.2 Chloramphenicol group	0.059	0.940	0.000
T48.5 Anti-common-cold drugs	0.058	0.941	0.000
T36.0 Penicillins	0.058	0.942	0.000
T36.3 Macrolides	0.056	0.944	0.000
T41.5 Therapeutic gases	0.055	0.945	0.000
T41.4 Anaesthetic, unspecified	0.055	0.945	0.000
T41.3 Local anaesthetics	0.055	0.945	0.000
T41.2 Other and unspecified general anaesthetics	0.055	0.945	0.000
T41.1 Intravenous anaesthetics	0.055	0.945	0.000
T41.0 Inhaled anaesthetics	0.055	0.945	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.055	0.945	0.000
T48.4 Expectorants	0.055	0.945	0.000
T48.3 Antitussives	0.055	0.945	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.055	0.945	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.055	0.945	0.000
T48.0 Oxytocic drugs	0.055	0.945	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.054	0.946	0.000
T37.5 Antiviral drugs	0.054	0.946	0.000
T37.4 Anthelminthics	0.054	0.946	0.000
T37.3 Other antiprotozoal drugs	0.054	0.946	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.054	0.946	0.000
T37.1 Antimycobacterial drugs	0.054	0.946	0.000
T37.0 Sulphonamides	0.054	0.946	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.054	0.946	0.000
T45.8 Other primarily systemic and haematological agents	0.054	0.946	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.054	0.946	0.000
T45.6 Fibrinolysis-affecting drugs	0.054	0.946	0.000
T45.4 Iron and its compounds	0.054	0.946	0.000
T45.3 Enzymes, not elsewhere classified	0.054	0.946	0.000
T49.9 Topical agent, unspecified	0.053	0.947	0.000
T49.8 Other topical agents	0.053	0.947	0.000
T49.7 Dental drugs, topically applied	0.053	0.947	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.053	0.947	0.000
T49.5 Ophthalmological drugs and preparations	0.053	0.947	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.053	0.947	0.000
T49.3 Emollients, demulcents and protectants	0.053	0.947	0.000
T49.2 Local astringents and local detergents	0.053	0.947	0.000
T49.1 Antipruritics	0.053	0.947	0.000
T40.2 Other opioids	0.053	0.947	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.052	0.948	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.051	0.949	0.000
T45.2 Vitamins, not elsewhere classified	0.051	0.949	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.050	0.949	0.000
T45.0 Antiallergic and antiemetic drugs	0.047	0.953	0.000
T40.1 Heroin	0.046	0.954	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.045	0.955	0.000
T40.8 Lysergide [LSD]	0.045	0.955	0.000
T40.7 Cannabis (derivatives)	0.045	0.955	0.000
T40.3 Methadone	0.045	0.955	0.000
T40.0 Opium	0.045	0.955	0.000
T45.5 Anticoagulants	0.045	0.955	0.000
T40.5 Cocaine	0.041	0.959	0.000
T40.6 Other and unspecified narcotics	0.039	0.961	0.000
M15.2 Bouchard's nodes (with arthropathy)	0.000	0.972	0.028
M15.1 Heberden's nodes (with arthropathy)	0.000	0.972	0.028
M15 Polyarthrosis	0.000	0.973	0.027
T40.4 Other synthetic narcotics	0.024	0.976	0.000
M15.4 Erosive (osteo)arthrosis	0.000	0.978	0.022
M15.8 Other polyarthrosis	0.000	0.978	0.022
M15.9 Polyarthrosis, unspecified	0.000	0.978	0.021
N90.8 Other specified noninflammatory disorders of vulva and perineum	0.000	0.980	0.020
M15.3 Secondary multiple arthrosis	0.000	0.981	0.019
M15.0 Primary generalised (osteo)arthrosis	0.000	0.982	0.018
M15.99 Polyosteoarthritis, unspecified	0.000	0.982	0.017
N90 Other noninflammatory disorders of vulva and perineum	0.000	0.983	0.017
N90.4 Leukoplakia of vulva	0.000	0.984	0.016
N90.3 Dysplasia of vulva, unspecified	0.000	0.984	0.016
N90.1 Moderate vulvar dysplasia	0.000	0.985	0.015
N90.0 Mild vulvar dysplasia	0.000	0.986	0.014
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.014	0.986	0.000
N90.6 Hypertrophy of vulva	0.000	0.987	0.013
N90.2 Severe vulvar dysplasia, not elsewhere classified	0.000	0.987	0.013
N90.9 Noninflammatory disorder of vulva and perineum, unspecified	0.000	0.988	0.012
M15.00 Primary generalized (osteo)arthrosis, Multiple sites	0.000	0.988	0.012
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.011	0.989	0.000
T43.9 Psychotropic drug, unspecified	0.010	0.990	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.010	0.990	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.010	0.990	0.000
C81.9 Hodgkin's disease, unspecified	0.000	0.990	0.010
T43.6 Psychostimulants with abuse potential	0.010	0.990	0.000
C84.4 Peripheral T-cell lymphoma	0.000	0.990	0.010
T43.5 Other and unspecified antipsychotics and neuroleptics	0.010	0.990	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.991	0.009
C84.5 Other and unspecified T-cell lymphomas	0.000	0.991	0.009
C81 Hodgkin's disease	0.000	0.991	0.009
T43.4 Butyrophenone and thioxanthene neuroleptics	0.008	0.991	0.000
N90.7 Vulvar cyst	0.000	0.992	0.008
T43.0 Tricyclic and tetracyclic antidepressants	0.008	0.992	0.000
C92.0 Acute myeloid leukaemia	0.008	0.992	0.000
C81.0 Lymphocytic predominance	0.000	0.992	0.008
N90.5 Atrophy of vulva	0.000	0.992	0.008
H57.1 Ocular pain	0.008	0.992	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.993	0.007
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.993	0.007
C88.0 Waldenstrom's macroglobulinaemia	0.000	0.993	0.007
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.993	0.007
C81.2 Mixed cellularity	0.000	0.993	0.007
C84.0 Mycosis fungoides	0.000	0.993	0.007
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.993	0.007
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.993	0.007
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.993	0.007
C84.3 Lymphoepithelioid lymphoma	0.000	0.993	0.007
C84.2 T-zone lymphoma	0.000	0.993	0.007
C84.1 Sezary's diease	0.000	0.993	0.007
C88 Malignant immunoproliferative diseases	0.000	0.993	0.007
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.000	0.993	0.007
C83.0 Small cell (diffuse)	0.000	0.993	0.007
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.993	0.007
C81.3 Lymphocytic depletion	0.000	0.993	0.007
C83.1 Small cleaved cell (diffuse)	0.000	0.993	0.007
C81.1 Nodular sclerosis	0.000	0.993	0.006
C81.7 Other Hodgkin's disease	0.000	0.994	0.006
K14.9 Disease of tongue, unspecified	0.006	0.994	0.000
E86 Volume depletion	0.000	0.994	0.006
C91.4 Hairy-cell leukaemia	0.000	0.994	0.006
C91 Lymphoid leukaemia	0.000	0.994	0.006
H57.0 Anomalies of pupillary function	0.006	0.994	0.000
C83.6 Undifferentiated (diffuse)	0.000	0.994	0.005
C83.5 Lymphoblastic (diffuse)	0.000	0.994	0.005
C83.4 Immunoblastic (diffuse)	0.000	0.994	0.005
C83.2 Mixed small and large cell (diffuse)	0.000	0.994	0.005
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.995	0.005
C94 Other leukaemias of specified cell type	0.000	0.995	0.005
Z93.3 Colostomy status	0.000	0.995	0.005
Z08.8 Follow-up examination after other treatment for malignant neoplasm	0.005	0.995	0.000
H57 Other disorders of eye and adnexa	0.005	0.995	0.000
C86 Other specified types of T/NK-cell lymphoma	0.000	0.995	0.005
C88.9 Malignant immunoproliferative disease, unspecified	0.000	0.995	0.005
C88.7 Other malignant immunoproliferative diseases	0.000	0.995	0.005
C88.3 Immunoproliferative small intestinal disease	0.000	0.995	0.005
C88.2 Gamma heavy chain disease	0.000	0.995	0.005
C88.1 Alpha heavy chain disease	0.000	0.995	0.005
C93 Monocytic leukaemia	0.000	0.995	0.005
E80.4 Gilbert's syndrome	0.005	0.995	0.000
C92 Myeloid leukaemia	0.002	0.995	0.003
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.995	0.005
C91.5 Adult T-cell leukaemia	0.000	0.995	0.005
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.995	0.005
K14.0 Glossitis	0.005	0.995	0.000
C83.3 Large cell (diffuse)	0.000	0.995	0.005
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.000	0.995	0.004
T43.3 Phenothiazine antipsychotics and neuroleptics	0.004	0.995	0.000
K14 Diseases of tongue	0.005	0.995	0.000
C83.7 Burkitt's tumour	0.000	0.995	0.004
H57.9 Disorder of eye and adnexa, unspecified	0.004	0.996	0.000
C95 Leukaemia of unspecified cell type	0.000	0.996	0.004
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.996	0.004
C91.7 Other lymphoid leukaemia	0.000	0.996	0.004
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.996	0.004
C91.3 Prolymphocytic leukaemia	0.000	0.996	0.004
C91.2 Subacute lymphocytic leukaemia	0.000	0.996	0.004
C91.0 Acute lymphoblastic leukaemia	0.000	0.996	0.004
C94.7 Other specified leukaemias	0.000	0.996	0.004
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.000	0.996	0.004
C94.5 Acute myelofibrosis	0.000	0.996	0.004
C94.4 Acute panmyelosis	0.000	0.996	0.004
C94.3 Mast cell leukaemia	0.000	0.996	0.004
C94.2 Acute megakaryoblastic leukaemia	0.000	0.996	0.004
C94.1 Chronic erythraemia	0.000	0.996	0.004
C94.0 Acute erythraemia and erythroleukaemia	0.000	0.996	0.004
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.996	0.004
C96.8 Histiocytic sarcoma	0.000	0.996	0.004
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.996	0.004
C96.6 Unifocal Langerhans-cell histiocytosis	0.000	0.996	0.004
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.000	0.996	0.004
C96.4 Sarcoma of dendritic cells (accessory cells)	0.000	0.996	0.004
C96.3 True histiocytic lymphoma	0.000	0.996	0.004
C96.2 Malignant mast cell tumour	0.000	0.996	0.004
C96.1 Malignant histiocytosis	0.000	0.996	0.004
C96.0 Letterer-Siwe disease	0.000	0.996	0.004
C90.1 Plasma cell leukaemia	0.000	0.996	0.004
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.996	0.004
C86.4 Blastic NK-cell lymphoma	0.000	0.996	0.004
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.000	0.996	0.004
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.000	0.996	0.004
C86.1 Hepatosplenic T-cell lymphoma	0.000	0.996	0.004
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.000	0.996	0.004
Y84.0 Cardiac catheterisation	0.004	0.996	0.000
T43.2 Other and unspecified antidepressants	0.004	0.996	0.000
C93.9 Monocytic leukaemia, unspecified	0.000	0.996	0.004
C93.7 Other monocytic leukaemia	0.000	0.996	0.004
C93.3 Juvenile myelomonocytic leukaemia	0.000	0.996	0.004
C93.2 Subacute monocytic leukaemia	0.000	0.996	0.004
C93.0 Acute monocytic leukaemia	0.000	0.996	0.004
C86.5 Angioimmunoblastic T-cell lymphoma	0.000	0.996	0.004
C90.0 Multiple myeloma	0.000	0.996	0.004
K14.6 Glossodynia	0.004	0.996	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.002	0.996	0.002
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.002	0.996	0.002
C92.3 Myeloid sarcoma	0.002	0.996	0.002
C92.2 Subacute myeloid leukaemia	0.002	0.996	0.002
C92.5 Acute myelomonocytic leukaemia	0.002	0.996	0.002
C92.9 Myeloid leukaemia, unspecified	0.002	0.996	0.002
D23.7 Skin of lower limb, including hip	0.004	0.996	0.000
C92.7 Other myeloid leukaemia	0.002	0.996	0.002
C93.1 Chronic monocytic leukaemia	0.000	0.996	0.003
C92.4 Acute promyelocytic leukaemia	0.002	0.996	0.002
C91.9 Lymphoid leukaemia, unspecified	0.000	0.996	0.004
C90.3 Solitary plasmacytoma	0.000	0.996	0.003
K14.5 Plicated tongue	0.003	0.996	0.000
K14.4 Atrophy of tongue papillae	0.003	0.996	0.000
K14.2 Median rhomboid glossitis	0.003	0.996	0.000
K14.1 Geographic tongue	0.003	0.996	0.000
C95.7 Other leukaemia of unspecified cell type	0.000	0.997	0.003
C95.2 Subacute leukaemia of unspecified cell type	0.000	0.997	0.003
C95.0 Acute leukaemia of unspecified cell type	0.000	0.997	0.003
K14.8 Other diseases of tongue	0.003	0.997	0.000
G91.9 Hydrocephalus, unspecified	0.003	0.997	0.000
K82.2 Perforation of gallbladder	0.000	0.997	0.003
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.997	0.003
K14.3 Hypertrophy of tongue papillae	0.003	0.997	0.000
C92.1 Chronic myeloid leukaemia	0.001	0.997	0.002
S20.3 Other superficial injuries of front wall of thorax	0.003	0.997	0.000
W07.9 Unspecified place	0.003	0.997	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.997	0.003
C90.2 Plasmacytoma, extramedullary	0.000	0.997	0.003
S20.2 Contusion of thorax	0.003	0.997	0.000
Z49.0 Preparatory care for dialysis	0.000	0.997	0.003
C95.9 Leukaemia, unspecified	0.000	0.997	0.002
S20 Superficial injury of thorax	0.003	0.997	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.997	0.003
T21.3 Burn of third degree of trunk	0.000	0.997	0.003
S20.8 Superficial injuries of other and unspecified parts of thorax	0.003	0.997	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.997	0.003
G31.9 Degenerative disease of nervous system, unspecified	0.003	0.997	0.000
S62.00 Fracture of navicular [scaphoid] bone of hand (closed)	0.000	0.998	0.002
C85.0 Lymphosarcoma	0.000	0.998	0.002
S20.4 Other superficial injuries of back wall of thorax	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.998	0.002
Z01.4 Gynaecological examination (general)(routine)	0.002	0.998	0.000
H73.8 Other specified disorders of tympanic membrane	0.002	0.998	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.002	0.998	0.000
G91.8 Other hydrocephalus	0.002	0.998	0.000
T21 Burn and corrosion of trunk	0.000	0.998	0.002
E80.6 Other disorders of bilirubin metabolism	0.002	0.998	0.000
T22.3 Burn of third degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
T20 Burn and corrosion of head and neck	0.000	0.998	0.002
T20.1 Burn of first degree of head and neck	0.000	0.998	0.002
G91 Hydrocephalus	0.002	0.998	0.000
T85.6 Mechanical complication of other specified internal prosthetic devices, implants and grafts	0.002	0.998	0.000
M19.09 Primary arthrosis of other joints (Site unspecified)	0.000	0.998	0.002
T22.2 Burn of second degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
M19.03 Primary arthrosis of other joints (Forearm)	0.000	0.998	0.002
M19.02 Primary arthrosis of other joints (Upper arm)	0.000	0.998	0.002
Z01.9 Special examination, unspecified	0.002	0.998	0.000
T20-T25 Burns and corrosions of external body surface, specified by site	0.000	0.998	0.002
S20.7 Multiple superficial injuries of thorax	0.002	0.998	0.000
T24.2 Burn of second degree of hip and lower limb, except ankle and foot	0.000	0.998	0.002
H57.8 Other specified disorders of eye and adnexa	0.002	0.998	0.000
N08.3 Glomerular disorders in diabetes mellitus	0.000	0.998	0.002
O41.8 Other specified disorders of amniotic fluid and membranes	0.000	0.998	0.002
T86.0 Bone-marrow transplant rejection	0.002	0.998	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.000	0.998	0.002
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.000	0.998	0.002
D76.3 Other histiocytosis syndromes	0.002	0.998	0.000
H74.9 Disorder of middle ear and mastoid, unspecified	0.002	0.998	0.000
C82.6 Cutaneous follicle centre lymphoma	0.000	0.998	0.002
C82.5 Diffuse follicle centre lymphoma	0.000	0.998	0.002
S66.1 Injury of flexor muscle and tendon of other finger at wrist and hand level	0.002	0.998	0.000
T21.2 Burn of second degree of trunk	0.000	0.998	0.002
T21.1 Burn of first degree of trunk	0.000	0.998	0.002
C09.9 Tonsil, unspecified	0.000	0.998	0.002
S27.20 Traumatic haemopneumothorax (without open wound into thoracic cavity)	0.002	0.998	0.000
G91.1 Obstructive hydrocephalus	0.002	0.998	0.000
G91.0 Communicating hydrocephalus	0.002	0.998	0.000
Z39.1 Care and examination of lactating mother	0.000	0.998	0.002
S22.30 Fracture of rib (closed)	0.002	0.998	0.000
C82.3 Follicular lymphoma grade IIIa	0.000	0.998	0.002
T20.2 Burn of second degree of head and neck	0.000	0.998	0.002
H35.4 Peripheral retinal degeneration	0.002	0.998	0.000
I89.0 Lymphoedema, not elsewhere classified	0.000	0.998	0.002
M19.0 Primary arthrosis of other joints	0.000	0.998	0.002
X49.9 Unspecified place	0.000	0.998	0.002
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.002	0.998	0.000
Z49.1 Extracorporeal dialysis	0.000	0.998	0.002
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.002	0.998	0.000
C50.2 Upper-inner quadrant of breast	0.002	0.998	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.002	0.998	0.000
E80.5 Crigler-Najjar syndrome	0.002	0.998	0.000
E80.3 Defects of catalase and peroxydase	0.002	0.998	0.000
E80.0 Hereditary erythropoietic porphyria	0.002	0.998	0.000
S27.0 Traumatic pneumothorax	0.002	0.998	0.000
M19.01 Primary arthrosis of other joints (Shoulder region)	0.000	0.998	0.002
S20.0 Contusion of breast	0.002	0.998	0.000
T20.0 Burn of unspecified degree of head and neck	0.000	0.998	0.002
T21.7 Corrosion of third degree of trunk	0.000	0.998	0.002
T21.6 Corrosion of second degree of trunk	0.000	0.998	0.002
T21.5 Corrosion of first degree of trunk	0.000	0.998	0.002
T21.4 Corrosion of unspecified degree of trunk	0.000	0.998	0.002
T24.3 Burn of third degree of hip and lower limb, except ankle and foot	0.000	0.998	0.002
M19.04 Primary arthrosis of other joints (Hand)	0.000	0.998	0.002
S62.70 Multiple fractures of fingers (closed)	0.000	0.998	0.002
E80.1 Porphyria cutanea tarda	0.002	0.998	0.000
S27.2 Traumatic heamopneumothorax	0.002	0.998	0.000
T20.7 Corrosion of third degree of head and neck	0.000	0.998	0.002
T20.6 Corrosion of second degree of head and neck	0.000	0.998	0.002
T20.5 Corrosion of first degree of head and neck	0.000	0.998	0.002
T20.4 Corrosion of unspecified degree of head and neck	0.000	0.998	0.002
T20.3 Burn of third degree of head and neck	0.000	0.998	0.002
T22.7 Corrosion of third degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
T22.6 Corrosion of second degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
T22.5 Corrosion of first degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
T22.4 Corrosion of unspecified degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
G91.3 Posttraumatic hydrocephalus, unspecified	0.002	0.998	0.000
T23 Burn and corrosion of wrist and hand	0.000	0.998	0.002
S42.10 Fracture of scapula (closed)	0.000	0.998	0.002
S27.01 Traumatic pneumothorax (with open wound into thoracic cavity)	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.000	0.998	0.002
T22.0 Burn of unspecified degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
T86.8 Failure and rejection of other transplanted organs and tissues	0.002	0.998	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.998	0.002
S27 Injury of other and unspecified intrathoracic organs	0.002	0.998	0.000
C82.4 Follicular lymphoma grade IIIb	0.000	0.998	0.002
Z01.7 Laboratory examination	0.002	0.998	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.998	0.002
S81.8 Open wound of other parts of lower leg	0.002	0.998	0.000
T22.1 Burn of first degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
T24.7 Corrosion of third degree of hip and lower limb, except ankle and foot	0.000	0.998	0.002
T24.6 Corrosion of second degree of hip and lower limb, except ankle and foot	0.000	0.998	0.002
T24.5 Corrosion of first degree of hip and lower limb, except ankle and foot	0.000	0.998	0.002
T24.4 Corrosion of unspecified degree of hip and lower limb, except ankle and foot	0.000	0.998	0.002
C82.2 Large cell, follicular	0.000	0.998	0.002
I89.1 Lymphangitis	0.000	0.998	0.002
T23.2 Burn of second degree of wrist and hand	0.000	0.998	0.002
M19.05 Primary arthrosis of other joints (Pelvic region and thigh)	0.000	0.998	0.002
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.998	0.002
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.998	0.002
E80.2 Other porphyria	0.002	0.998	0.000
T21.0 Burn of unspecified degree of trunk	0.000	0.998	0.002
H81.0 Meniere's disease	0.002	0.998	0.000
S20.1 Other and unspecified superficial injuries of breast	0.001	0.998	0.000
C49.2 Connective and soft tissue of lower limb, including hip	0.002	0.998	0.000
K09.2 Other cysts of jaw	0.000	0.998	0.002
L92.0 Granuloma annulare	0.002	0.998	0.000
S27.8 Injury of other specified intrathoracic organs	0.002	0.998	0.000
H55-H59 Other disorders of eye and adnexa	0.002	0.998	0.000
M19.06 Primary arthrosis of other joints-Lower leg	0.000	0.998	0.002
G91.2 Normal-pressure hydrocephalus	0.002	0.998	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.000	0.998	0.002
S27.21 Traumatic haemopneumothorax (with open wound into thoracic cavity)	0.002	0.998	0.000
S42.20 Fracture of upper end of humerus (closed)	0.000	0.998	0.002
X58.9 Unspecified place	0.000	0.998	0.002
M87.20 Osteonecrosis due to previous trauma (Multiple sites)	0.002	0.998	0.000
S27.3 Other injuries of lung	0.002	0.998	0.000
T23.7 Corrosion of third degree of wrist and hand	0.000	0.998	0.002
T23.6 Corrosion of second degree of wrist and hand	0.000	0.998	0.002
T23.5 Corrosion of first degree of wrist and hand	0.000	0.998	0.002
T23.4 Corrosion of unspecified degree of wrist and hand	0.000	0.998	0.002
T23.0 Burn of unspecified degree of wrist and hand	0.000	0.998	0.002
T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot	0.000	0.998	0.002
T84.9 Unspecified complication of internal orthopaedic prosthetic device, implant and graft	0.000	0.998	0.002
D86.9 Sarcoidosis, unspecified	0.000	0.998	0.002
M19.08 Primary arthrosis of other joints (Other)	0.000	0.998	0.002
J95.8 Other postprocedural respiratory disorders	0.000	0.998	0.002
S62.0 Fracture of navicular [scaphoid] bone of hand	0.000	0.998	0.002
S27.9 Injury of unspecified intrathoracic organ	0.001	0.998	0.000
S27.7 Multiple injuries of intrathoracic organs	0.001	0.998	0.000
S27.6 Injury of pleura	0.001	0.998	0.000
S27.5 Injury of thoracic trachea	0.001	0.998	0.000
S27.4 Injury of bronchus	0.001	0.998	0.000
T24.1 Burn of first degree of hip and lower limb, except ankle and foot	0.000	0.998	0.001
T25 Burn and corrosion of ankle and foot	0.000	0.998	0.001
Z01 Other special examinations and investigations of persons without complaint or reported diagnosis	0.002	0.998	0.000
T79.7 Traumatic subcutaneous emphysema	0.002	0.998	0.000
S62.51 Fracture of thumb (open)	0.000	0.998	0.002
T23.1 Burn of first degree of wrist and hand	0.000	0.998	0.001
S27.80 Injury of other specified intrathoracic organs (without open wound into thoracic cavity)	0.001	0.998	0.000
I89.9 Non-infective disorder of lymphatic vessels and lymph nodes, unspecified	0.000	0.998	0.002
T23.3 Burn of third degree of wrist and hand	0.000	0.998	0.001
T86.4 Liver transplant failure and rejection	0.002	0.998	0.000
Z01.1 Examination of ears and hearing	0.001	0.998	0.000
O66.0 Obstructed labour due to shoulder dystocia	0.002	0.998	0.000
T86 Failure and rejection of transplanted organs and tissues	0.002	0.998	0.000
Z49 Care involving dialysis	0.000	0.998	0.002
M47.87 Other spondylosis (Lumbosacral region)	0.002	0.998	0.000
I89 Other non-infective disorders of lymphatic vessels and lymph nodes	0.000	0.998	0.002
M25.85 Other specified joint disorders (Pelvic region and thigh)	0.000	0.998	0.002
S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level	0.002	0.998	0.000
X63.0 Home	0.001	0.998	0.000
S27.30 Other injuries of lung (without open wound into thoracic cavity)	0.001	0.998	0.000
S27.81 Injury of other specified intrathoracic organs (with open wound into thoracic cavity)	0.001	0.998	0.000
T25.3 Burn of third degree of ankle and foot	0.000	0.998	0.001
M25.54 Pain in joint (Hand)	0.000	0.998	0.002
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.001	0.998	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.000	0.998	0.001
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.000	0.998	0.001
N08.1 Glomerular disorders in neoplastic diseases	0.000	0.998	0.001
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.001
Z01.3 Examination of blood pressure	0.001	0.998	0.000
C66 Malignant neoplasm of ureter	0.000	0.998	0.001
S27.31 Other injuries of lung (with open wound into thoracic cavity)	0.001	0.999	0.000
S22.3 Fracture of rib	0.001	0.999	0.000
S62.01 Fracture of navicular [scaphoid] bone of hand (open)	0.000	0.999	0.001
N49.2 Inflammatory disorders of scrotum	0.000	0.999	0.001
X49.6 Industrial and construction area	0.000	0.999	0.001
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues	0.000	0.999	0.001
S27.41 Injury of bronchus (with open wound into thoracic cavity)	0.001	0.999	0.000
S27.40 Injury of bronchus (without open wound into thoracic cavity)	0.001	0.999	0.000
S27.51 Injury of thoracic trachea (with open wound into thoracic cavity)	0.001	0.999	0.000
S27.50 Injury of thoracic trachea (without open wound into thoracic cavity)	0.001	0.999	0.000
S27.61 Injury of pleura (with open wound into thoracic cavity)	0.001	0.999	0.000
S27.60 Injury of pleura (without open wound into thoracic cavity)	0.001	0.999	0.000
S27.71 Multiple injuries of intrathoracic organs (with open wound into thoracic cavity)	0.001	0.999	0.000
S27.70 Multiple injuries of intrathoracic organs (without open wound into thoracic cavity)	0.001	0.999	0.000
S27.91 Injury of unspecified intrathoracic organ (with open wound into thoracic cavity)	0.001	0.999	0.000
S27.90 Injury of unspecified intrathoracic organ (without open wound into thoracic cavity)	0.001	0.999	0.000
T25.7 Corrosion of third degree of ankle and foot	0.000	0.999	0.001
T25.6 Corrosion of second degree of ankle and foot	0.000	0.999	0.001
T25.5 Corrosion of first degree of ankle and foot	0.000	0.999	0.001
T25.4 Corrosion of unspecified degree of ankle and foot	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations